Your browser doesn't support javascript.
loading
Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse.
Lim, Andrew B M; Curley, Cameron; Fong, Chun Y; Bilmon, Ian; Beligaswatte, Ashanka; Purtill, Duncan; Getta, Bartlomiej; Johnston, Anne M; Armytage, Tasman; Collins, Marnie; Mason, Kate; Fielding, Katherine; Greenwood, Matthew; Gibson, John; Hertzberg, Mark; Wright, Matthew; Lewis, Ian; Moore, John; Curtis, David; Szer, Jeff; Kennedy, Glen; Ritchie, David.
  • Lim ABM; Department of Clinical Haematology and BMT Service, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Curley C; The University of Melbourne, Melbourne, Victoria, Australia.
  • Fong CY; Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Bilmon I; Department of Clinical Haematology, The Alfred, Melbourne, Victoria, Australia.
  • Beligaswatte A; Haematology Department, St Vincent's Hospital, Sydney, New South Wales, Australia.
  • Purtill D; Department of Haematology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Getta B; Clinical Haematology Bone Marrow Transplant Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Johnston AM; Department of Haematology, Royal Perth Hospital, Perth, Western Australia, Australia.
  • Armytage T; Department of Haematology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Collins M; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Mason K; Haematology Department, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Fielding K; Centre for Biostatistics and Clinical Trials, Melbourne, Victoria, Australia.
  • Greenwood M; Department of Clinical Haematology and BMT Service, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Gibson J; Department of Clinical Haematology and BMT Service, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Hertzberg M; Haematology Department, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Wright M; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Lewis I; The University of Sydney, Sydney, New South Wales, Australia.
  • Moore J; Department of Haematology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Curtis D; Department of Haematology, Royal Perth Hospital, Perth, Western Australia, Australia.
  • Szer J; Clinical Haematology Bone Marrow Transplant Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Kennedy G; Haematology Department, St Vincent's Hospital, Sydney, New South Wales, Australia.
  • Ritchie D; Department of Clinical Haematology, The Alfred, Melbourne, Victoria, Australia.
Intern Med J ; 48(3): 276-285, 2018 03.
Article en En | MEDLINE | ID: mdl-28628276
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article